CASE 0:08-md[removed]JRT Document[removed]Filed[removed]Page 1 of 2 UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

First Page		Document Content
Date: 2011-03-09 14:31:24 Lawsuit Plaintiff Ortho-McNeil-Janssen Ortho-McNeil Pharmaceutical Multidistrict litigation Chemistry Organic chemistry Johnson & Johnson Levofloxacin Piperazines		CASE 0:08-md[removed]JRT Document[removed]Filed[removed]Page 1 of 2 UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA Add to Reading List Source URL: www.mnd.uscourts.gov Download Document from Source Website File Size: 22,21 KB Share Document on Facebook

	JACQUELINE BROWN, M.S, PHD, RN 2815 Canyon Creek San Angelo, Texas[removed]removed] CURRICULUM VITAE (2012) DocID: NRGM - View Document
	March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc DocID: Mj7H - View Document
	Kentucky Medicaid Pharmacy 3Q2011 Active Labelers List Labeler ID Labeler Name DocID: L8ds - View Document
	McNeil Consumer Healthcare Division of McNeil – PPC, Inc[removed]Camp Hill Road, Fort Washington, PA[removed]-7000 ADDENDUM DocID: FwJP - View Document
	Patterns and predictors of suicides in the U.S. Army: An introduction to the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) Ronald C. Kessler, Ph.D. Harvard Medical School DocID: FnXO - View Document